Stay updated on Nivolumab Plus Ipilimumab in Melanoma Clinical Trial

Sign up to get notified when there's something new on the Nivolumab Plus Ipilimumab in Melanoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Nivolumab Plus Ipilimumab in Melanoma Clinical Trial page

  1. Check
    yesterday
    Change Detected
    Summary
    The page revision is updated to v3.6.5, and Melanoma-related terms and the Investigator Inquiry Form are removed, altering disease labeling and access to investigator contact, while a new revision tag is added.
    Difference
    0.1%
    Check dated 2026-08-08T10:25:42.000Z thumbnail image
  2. Check
    8 days ago
    No Change Detected
  3. Check
    16 days ago
    Change Detected
    Summary
    Added Melanoma and MedlinePlus Genetics to the related topics section. The revision tag was updated from v3.6.3 to v3.6.4.
    Difference
    0.1%
    Check dated 2026-07-25T06:39:56.000Z thumbnail image
  4. Check
    23 days ago
    Change Detected
    Summary
    The Melanoma disease label and the related topics section (MedlinePlus Genetics) were removed from the study's metadata, altering how the study is described and linked to broader health topics.
    Difference
    0.1%
    Check dated 2026-07-18T01:38:13.000Z thumbnail image
  5. Check
    30 days ago
    Change Detected
    Summary
    Melanoma and MedlinePlus Genetics were added to the page as related topics, providing disease context and a link to genetic resources. This change expands navigation to related information without altering the core study data.
    Difference
    0.1%
    Check dated 2026-07-10T22:50:19.000Z thumbnail image
  6. Check
    37 days ago
    Change Detected
    Summary
    The revision label on the page changed from v3.6.2 to v3.6.3, indicating a new build behind the interface.
    Difference
    0.0%
    Check dated 2026-07-03T22:09:05.000Z thumbnail image
  7. Check
    44 days ago
    Change Detected
    Summary
    The page’s revision label was updated from v3.6.0 to v3.6.2. This indicates a backend or UI patch, while the study details and page content remain unchanged.
    Difference
    0.0%
    Check dated 2026-06-26T19:34:35.000Z thumbnail image

Stay in the know with updates to Nivolumab Plus Ipilimumab in Melanoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Nivolumab Plus Ipilimumab in Melanoma Clinical Trial page.